- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03443986
Effect of Resistance Training Associated With Whole-Body Vibration in Diabetes
Effect of Resistance Training Associated With Whole-Body Vibration Over the Peripheral Circulation and the Functional Performance of the Elderly With Type 2 Diabetes: Randomized Controlled Clinical Trial
Introduction: Diabetes Mellitus (DM) is an important health condition of the population and its prevalence continues to grow due to population aging, economic development and urbanization. The exercise is an important factor of prevention and control, thereby decreasing the risk of metabolic diseases, cardiovascular diseases and improving the functionality of the patient with diabetes.
Objective: Evaluate the response of resistance training associated with whole-body vibration on peripheral circulation and functional performance of elderly with type 2 diabetes.
Methods: This is a clinical trial study, controlled, randomized and blinded, which will follow the guidelines established by the Consolidated Standards of Reporting Trials (CONSORT). Patients will be recruited in the light of the eligibility criteria and randomly divided into 3 groups: resistance training associated with whole body vibration (G1), resistance training associated with vibration sham (G2) and control group-guidelines about foot care (GC), establishing 36 treatment sessions, three times a week for the G1 and G2.
Study Overview
Status
Conditions
Study Type
Enrollment (Anticipated)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Pernambuco
-
Recife, Pernambuco, Brazil, 51020240
- Recruiting
- François Talles Medeiros Rodrigues
-
Contact:
- François Talles M Rodrigues, Msc
- Phone Number: 81998432083
- Email: francoismedeirosfisiot@gmail.com
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Present overweight or obese class I, with BMI between 25.00 and 34.99 kg/m2 (WHO, 2009)
- Be functionally independent
- Having cognitive ability to respond and perform the exercisesevaluated by Mini-Mental State examination (MMSE), prepared by Folstein et al. (1975) and translation/modification proposed by Lawrence and van Heerden (2006), using as a bridge to cut to illiterate individuals = 19 points (BRAZIL, 2006)
- Inactive (0 to 5 points) or less active (6 to 11 points) according to the Questionnaire of Habitual Physical Activity (QAFH)
- Patients without severe foot deformities requiring therapeutic shoes
- Do not have orthopedic deficiencies
- No indications of deep vein thrombosis
- Do not use locomotion auxiliary equipment
Exclusion Criteria:
- Change in the drug program in during the research
- Performing other physical activity during the training
- Hypertensive Peaks during treatment
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Triple
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Resistance training associated with vibration
The workout will be held three times a week and will last a total of 12 weeks (3 months) for 45 minutes.
|
The workout will be held three times a week and will last a total of 12 weeks (3 months) for 45 minutes, where there will be 5 minutes of heating, 19 minutes of exercise with load, 16 minutes of vibration and 5 minutes of slowdown.
|
Sham Comparator: Resistance training associated with sham
The workout will be held three times a week and will last a total of 12 weeks (3 months) for 45 minutes, where there will be 5 minutes of heating, 19 minutes of exercise with load, 16 minutes of vibration "sham" and 5 minutes of slowdown.
The vibration sham; will be held with the disconnected platform.
A device will be connected producing a noise similar to the sound of the connected platform for a time equivalent to the treatment protocol, since it will not be possible to distinguishing noticeably stimulate vibrator.
Participants that will undergo false vibration will not have contact with those who carry out the real treatment.
|
he workout will be held three times a week and will last a total of 12 weeks (3 months) for 45 minutes, where there will be 5 minutes of heating, 19 minutes of exercise with load, 16 minutes of vibration "sham" and 5 minutes of slowdown.
|
No Intervention: Control group
Will not be submitted to any physical intervention.
It continues in your daily life with only monitoring via phone callings.
Guidelines about foot care.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Peripheral circulation
Time Frame: 12 weeks
|
Vascular Doppler ultrasound (UVD)
|
12 weeks
|
Functional performance
Time Frame: 12 weeks
|
Timed Up and Go Test (TUG)
|
12 weeks
|
Peripheral circulation
Time Frame: 12 weeks
|
Infrared Thermography (TI)
|
12 weeks
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Static postural alignment
Time Frame: 12 weeks
|
Optoeletrônico system SMART DX100
|
12 weeks
|
Plantar pressure distribution
Time Frame: 12 weeks
|
Baropodometry
|
12 weeks
|
Collaborators and Investigators
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- Resistance, Vibration and DM
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Diabetes Mellitus, Type 2
-
SanofiCompletedType 1 Diabetes Mellitus-Type 2 Diabetes MellitusHungary, Russian Federation, Germany, Poland, Japan, United States, Finland
-
Mannkind CorporationTerminatedType 2 Diabetes Mellitus | Type 1 Diabetes MellitusUnited States
-
RWTH Aachen UniversityBoehringer IngelheimCompletedDiabetes Mellitus Type 2 (T2DM)Germany
-
University Hospital Inselspital, BerneCompletedType 2 Diabetes MellitusSwitzerland
-
India Diabetes Research Foundation & Dr. A. Ramachandran...CompletedTYpe 2 Diabetes MellitusIndia
-
Griffin HospitalCalifornia Walnut CommissionCompletedDIABETES MELLITUS TYPE 2United States
-
Scripps Whittier Diabetes InstituteSan Diego State UniversityCompletedType 2 Diabetes Mellitus (T2DM)United States
-
US Department of Veterans AffairsAmerican Diabetes AssociationCompletedType 2 Diabetes MellitusUnited States
-
Dexa Medica GroupCompletedType-2 Diabetes MellitusIndonesia
-
AstraZenecaRecruiting
Clinical Trials on Resistance training associated with vibration
-
Wingate InstituteCompletedMuscle Strength | Disabilities of the Arm, Shoulder and HandIsrael
-
University Hospital, GhentAgentschap voor Innovatie door Wetenschap en TechnologieCompletedRespiratory CancerBelgium
-
University Hospital, GhentCompleted
-
Asociacion Colaboracion Cochrane IberoamericanaCompleted
-
Yuxiang LiangCompleted
-
King Saud UniversityCompleted
-
Riphah International UniversityCompletedCOVID-19 PandemicPakistan
-
University of MichiganEunice Kennedy Shriver National Institute of Child Health and Human Development... and other collaboratorsCompletedAnterior Cruciate Ligament InjuryUnited States
-
Universidade Federal do CearáNot yet recruiting